German phenytoin formulation compatible with intravenous fluids
Reith, H.
American Journal of Hospital Pharmacy 36(10): 1317
1979
ISSN/ISBN: 0002-9289 PMID: 507070 Document Number: 149431
Document emailed within 1 workday
Related Documents
Cloyd, J.C.; Bosch, D.E.; Sawchuk, R.J. 1978: Concentration-time profile of phenytoin after admixture with small volumes of intravenous fluids American Journal of Hospital Pharmacy 35(1): 45-48Koren, G.; Brand, N.; Halkin, H.; Dany, S.; Shahar, E.; Barzilay, Z. 1984: Kinetics of intravenous phenytoin in children Pediatric Pharmacology 4(1): 31-38
Chauplannaz, G.; Mauguière, F.; Courjon, J.; Ferry, S. 1981: Use of intravenous phenytoin in treatment of partial status epilepticus La Nouvelle Presse Medicale 10(13): 1043-1046
Gatti, G.; Perucca, E.; Caravaggi, M.; Poloni, M.; Frigo, G.M.; Crema, A. 1977: Pharmacokinetics of phenytoin following intravenous administration in epileptic patients Il Farmaco; Edizione Pratica 32(9): 470-474
Endoh, T.; Miyake, S. 2001: A case of purple glove syndrome following a intravenous infusion of phenytoin No to Hattatsu 33(5): 442-444
Earnest, M.P.; Marx, J.A.; Drury, L.R. 1983: Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage JAMA 249(6): 762-765
Tiamkao, S.; Chitravas, N.; Jitpimolmard, S.; Sawanyawisuth, K. 2005: Appropriateness of intravenous loading dose of phenytoin treatment in Srinagarind Hospital Journal of the Medical Association of Thailand 88(11): 1638-1641
Broadbent, R.; Pybus, J. 1986: Aluminium contamination of intravenous fluids in neonates New Zealand Medical Journal 99(797): 166-167
Marín, P.; Prat, G.; Serani, A. 1988: The dying patient: use of intravenous fluids and management of fever Revista Medica de Chile 116(9): 906-908
Stepniewska, E.; Stepniewski, M. 1978: Practical remarks on composition of some fluids used for intravenous infusions Przeglad Lekarski 35(8): 679-682
Hunt, J.A. 1976: The choice of intravenous fluids for resuscitation in hypovolaemic shock South African Medical Journal 50(42): 1647-1656
Hvidberg, E.; Bols, T.; Jacobsen, N. 1973: Incompatibility and other problems in adding drugs to intravenous fluids Ugeskrift for Laeger 135(24): 1221-1229
Arnold, T.R.; Hepler, C.D. 1971: Bacterial contamination of intravenous fluids opened in unsterile air American Journal of Hospital Pharmacy 28(8): 614-619
Wark, E. 1976: Chemotherapy and the nurse. 2. the interaction of drugs and intravenous fluids Nursing Mirror and Midwives Journal 142(13): 46-49
Henry, R.H.; Harrison, W.L. 1972: Problems in the use of volume control sets for intravenous fluids American Journal of Hospital Pharmacy 29(6): 485-490
Raineri, D.L.; Cwik, M.J.; Rodvold, K.A.; Deyo, K.L.; Scaros, L.P.; Fischer, J.H. 1988: Stability of nizatidine in commonly used intravenous fluids and containers American Journal of Hospital Pharmacy 45(7): 1523-1529
Aluoch-Orwa, J.A.; Ondari, C.O.; Kibwage, I.O.; Hoogmartens, J. 1995: Quality of intravenous infusion fluids manufactured in Kenya East African Medical Journal 72(12): 800-804
Moo, K.S.; Radhakrishnan, S.; Teoh, M.; Narayanan, P.; Bukhari, N.I.; Segarra, I. 2010: Disposition and tissue distribution of imatinib in a liposome formulation after intravenous bolus dose to mice Yao Xue Xue Bao 45(7): 901-908
Jefferys, R.J. 2005: Lower phenytoin serum levels in persons switched from brand to generic phenytoin Neurology 65(4): 657-8; Author Reply 657-8
Wierzchowiecki, M.; Swiderczuk, A.; Dyderski, S.; Masiakowski, J.; Jazienicki, B. 1987: Studies of the biological availability of phenytoin preparations (Polfa) and micronized phenytoin in patients with cardiac rhythm disorders Kardiologia Polska 30(9): 577-582